Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO.B - Get Free Report) saw strong trading volume on Wednesday . 218 shares were traded during trading, a decline of 22% from the previous session's volume of 280 shares.The stock last traded at $359.22 and had previously closed at $357.05.
Bio-Rad Laboratories Stock Up 0.2 %
The firm's fifty day moving average is $336.01 and its 200-day moving average is $328.84. The company has a market capitalization of $10.01 billion, a P/E ratio of -13.09 and a beta of 0.72. The company has a debt-to-equity ratio of 0.16, a quick ratio of 4.52 and a current ratio of 6.14.
Bio-Rad Laboratories (NYSE:BIO.B - Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $2.01 earnings per share for the quarter. The business had revenue of $649.73 million for the quarter. Bio-Rad Laboratories had a positive return on equity of 3.74% and a negative net margin of 30.18%.
Bio-Rad Laboratories Company Profile
(
Get Free Report)
Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Bio-Rad Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bio-Rad Laboratories wasn't on the list.
While Bio-Rad Laboratories currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
